Navigation Links
Higher risk for cervical cancer seen among women infected with multiple HPV types

Although doctors have known that the cervical tissue at the opening to the womb can harbor multiple HPV types, this study is the first to document that the risk for developing cervical cancer, the second most common form of cancer in women worldwide, is higher in females infected with multiple HPV types than those infected with just one HPV type.

In addition, the study's findings provide baseline data for analyzing over time the impact of the newly approved vaccine, Gardasil, on the dynamics of HPV infection.

"Women who harbor multiple infections are at higher risk for cervical lesions than those ever infected with one type only and should be followed more closely," said Eduardo L. Franco, Dr.PH., leader of the study and professor of epidemiology and oncology, and director, division of cancer epidemiology at McGill University.

Like previous studies on HPV in cervical cancer, the new research found that pre-cancerous abnormalities primarily occurred in women infected with HPV 16 and 18, the targets of Gardasil.

The vaccine also will prevent infection by the HPV types 6 and 11 that are associated with genital warts, and thus is expected to prevent cervical cancer in thousands of women.

However, the vaccine will not protect against HPV 58, which the new study discovered to be far more oncogenic than others when found in co-infections with other HPV types. The study's findings suggest HPV 58 should be one of the targets of the next generation of cervical cancer vaccines.

Indeed, the scientists discovered that the higher risk associated with HPV 58 in co-infections was similar to that conferred by HPV 16 in co-infections. Both HPV 58 and 16 "seemed particularly prone to increase risk" for pre-cancerous lesions in the cervix, said Helen Trottier, Ph.D., the first author of the research paper.

Participating in the study were 2,000 women, ages 18 to 40, most of whom were Caucasian and lived in Brazil. The
'"/>

Source:American Association for Cancer Research


Page: 1 2 3

Related biology news :

1. Men Estimate Mens Risks Of Common Disorders Higher Than Women Do, And Vice Versa
2. Higher carbon dioxide, lack of nitrogen limit plant growth
3. Higher levels of obesity associated with greater health risks
4. Mass production of human papillomavirus could lead to gains against cervical cancer
5. High HPV concentrations combined with smoking significantly raise risks of cervical cancer
6. Temple University Hospital investigates treatment for cervical dysplasia
7. Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
8. Viral DNA sequence a possible trigger for breast cancer
9. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
10. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
11. Columbia research lifts major hurdle to gene therapy for cancer

Post Your Comments:
(Date:11/26/2009)...untries has shown that closing schools in the even...ignificant role in reducing illness transmission. ...C Infectious Diseases compared opportunities for ...nding that they were reduced when schools are shut...ty, Belgium, led a team of European researchers in...
(Date:11/25/2009)...h, may be used to boost resistance to, or slow, th...of Medicine researchers report in a study publishe...e . , Parkinson,s disease is caused by a degener...in known as the substantia nigra, which is respons...of dopamine in late-stage Parkinson,s causes sympt...
(Date:11/25/2009)...pumps some 250 million liters of blood through the...of the heart have to be extremely durable. The res... chair of the Department of Medicine III at Heidel.... Katus), has discovered a protein that is respons...it, the sarcomere. In cooperation with other resea...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference 51208 1Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference 51208 2Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference 51208 3Motion analysis helps soccer players get their kicks 51204 1Motion analysis helps soccer players get their kicks 51204 2Motion analysis helps soccer players get their kicks 51204 3European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2
...S July 1, 2008 The current standard practice of ...prevent brain damage caused by oxygen deprivation ...at UT Southwestern Medical Center have found. , B... hypoxic-ischemic brain injury, is one of the most... damage among infants and children. This can happe...
...olla, Calif., June 30, 2008--In a breakthrough sci...of the National Academy of Sciences , scientists a...shown that neural stem cell development may be lin...cking the myocyte enhancer factor 2C (MEF2C) prote...nerve cells and showed behaviors similar to those ...
...EY, CA The dream of personalized medicine in whi...isions are based on a patient,s genetic profile m...althiest of nations with state-of-the-art clinics.... Energy,s Lawrence Berkeley National Laboratory (B... or RNA assays the key to genetic profiling and d...
Other Biology News:Resuscitation technique after brain injury may do more harm than good 2Researchers link early stem cell mutation to autism 2New electrostatic-based DNA microarray technique could revolutionize medical diagnostics 2New electrostatic-based DNA microarray technique could revolutionize medical diagnostics 3New electrostatic-based DNA microarray technique could revolutionize medical diagnostics 4
(Date:11/24/2009)...EYKJAVIK, Iceland, November 24 /PRNewswire-FirstCa... announced that it has received notice from,the Na...mmon stock will be,suspended as of November 30, 20...ties and Exchange Commission, which will remove de... the company files an appeal to the Nasdaq,Listing...
(Date:11/24/2009)...ov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals In...(PTO) has allowed the patent application for,its n..., NOD technology is a highly efficient approa...hesive nano-particles to enable oral delivery of d...hnology is a platform technology,that can be appli...
(Date:11/24/2009)...FBI recently approved the Promega PowerPlex 16 HS ... generating DNA records for the National DNA Index...A (PRWEB) -- The FBI recently approved the Promega...ries participating in, or generating DNA records f...rently contains more than seven million profiles a...
(Date:11/24/2009).... 24, 2009 Arena Pharmac...that the company is scheduled to present at the Pi...December 1, 2009 at 11:30 a.m. Eastern Time (8:30 ... New York City. Jack Lief, Arena,s President and C... overview of the company, including its clinical d...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
..., Calif., Sept. 17 BioMarin,Pharmaceutical Inc. (...licensed to Asubio Pharma Co., Ltd. (a subsidiary ...tellectual property contained in the,Kuvan(TM) (sa...DA). Asubio,will use this data to supplement its c...Labour and Welfare for approval of its BH4 product...
...argest Pharmacy Distributor Introduces RESPeRATE H...try,s Retail Market, NEW YORK and LONDON, Sept. 1...hat its RESPeRATE(R) hypertension treatment device...significantly lower blood,pressure, will launch in...gh Mashco, Ltd., the country,s largest distributor...
...DGE, Mass. and NEW YORK, Sept. 17 ,Microbia, Inc. ... announced,that they have entered into a 50/50 par...-market Microbia,s first-in-class compound linaclo...for the treatment of,constipation-predominant irri... (CC), and other gastrointestinal disorders. (Log...
Other Biology Technology:Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 2Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 3Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 4InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 3InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 4Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 2Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 3Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 4Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 5
...s intended for first-time users of the PROTEAN IEF...a protein sample and reagents sufficient to rehydr...six 17 cm, ten 11 cm, or sixteen 7 cm ReadyStrip I...AGE gels and gels stains are not included in kit)....
Rabbit Anti-Lipid Phosphate Phosphatase 2 (LPP2) Antibody, Unconjugated from Sigma-Aldrich
Rabbit Anti-MAPKAPK-2, phospho (Thr222) Polyclonal Antibody, Unconjugated from Calbiochem
Rabbit Anti-SMURF 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: